USES SKYRIZI is a prescription medicine used to treat adults with: moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV …

Jun 18, 2024 · The most common side effects of SKYRIZI in people treated for Crohn's disease and ulcerative colitis include: upper respiratory infections, headache, joint pain, stomach (abdominal) …

Jul 23, 2024 · As a treatment for ulcerative colitis, Skyrizi works by fighting the inflammation that can lead to symptoms of the disease.

Patients should be evaluated for tuberculosis (TB) prior to starting this medication, and should not be given Skyrizi® if there is active TB. If there is a hypersensitivity reaction or anaphylaxis occurs, …

May 8, 2025 · What is the best medicine for ulcerative colitis? The treatment options for ulcerative colitis vary based on the disease’s severity and can be categorized into six main types: conventional …

Jun 19, 2024 · The US Food and Drug Administration (FDA) has approved Skyrizi (risankizumab-rzaa; AbbVie) for the treatment of moderately to severely active ulcerative colitis in adults. This approval …

SKYRIZI® is indicated for the treatment of moderately to severely active ulcerative colitis in adults. See Important Safety and Prescribing Information.

Jun 20, 2024 · The FDA has given its okay to the biologic drug Skyrizi (risankizumab) as a treatment for people with moderately to severely active ulcerative colitis. The medication works by blocking the …

Aug 11, 2025 · Skyrizi works to treat ulcerative colitis by attaching to certain proteins in your immune system. This helps reduce the excess inflammation that contributes to ulcerative colitis symptoms.

Risankizumab-rzaa may be used for the treatment of moderately to severely active UC in patients who have medical inadvisability to, or mechanistic failure of, a TNFi, or pharmacokinetic failure of …